Naproxen in otitis media with effusion
- 1 March 1986
- journal article
- clinical trial
- Published by Cambridge University Press (CUP) in The Journal of Laryngology & Otology
- Vol. 100 (3) , 263-266
- https://doi.org/10.1017/s0022215100099114
Abstract
The levels of prostaglandian E2(PGE2) were measured in aspirates of the effusion fluid from children suffering from secretory otitis media. The effects of naproxen 5 mg./kg. twice daily for eight weeks on the condition were studied in a placebocontrolled double-blind trial.Nineteen middle-ear aspiraes from 13 children, six of whom had bilateral aspirations were examined. Detectable levels of PGE2and those without.In a separate trial of naproxen, 11 patients received active drug and 13 received placebo. Naproxen had no significant effect on otalgia or hearing loss compared to placedo.These findings suggest that is it unlikely that non-steroidal anti-inflammatory drug will be of therapeutic benefit in secretory otitis media.Keywords
This publication has 6 references indexed in Scilit:
- Effect of Prostaglandin on the Composition of Chinchilla Middle Ear EffusionAnnals of Otology, Rhinology & Laryngology, 1980
- A radioimmunoassay for 6-keto- prostaglandin F1αProstaglandins, 1978
- The medical treatment of secretory otitis media A clinical trial of three commonly used regimesThe Journal of Laryngology & Otology, 1977
- Naproxen in the Treatment of Juvenile Rheumatoid Arthritis: Metabolism, safety and efficacyScandinavian Journal of Rheumatology, 1977
- Prostaglandins in Middle Ear EffusionsJAMA Otolaryngology–Head & Neck Surgery, 1976
- The Use of the Electro-Acoustic Impedance Bridge in the Assessment of Middle Ear FunctionInternational Audiology, 1969